Literature DB >> 17311976

Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the human NK-cell activity.

Kazuyoshi Takeda1, Ko Okumura.   

Abstract

Nine healthy middle-aged and 10 elderly volunteers drank fermented milk containing 4 x 10(10) live cells of Lactobacillus casei strain Shirota daily for 3 wk, and their natural killer (NK) activity and other immunological functions were examined. In the experiments with middle-aged volunteers, NK activity significantly increased (P<0.01) 3 wk after the start of intake, elevated NK cell activity remained for the next 3 wk, and this effect was particularly prominent in the low-NK-activity individuals. In the experiments with elderly volunteers, NK activity significantly decreased (P<0.01) in the control group 3 wk after the start of intake; however, the intake of Lactobacillus casei strain Shirota maintained the NK activity. These results suggest that daily intake of Lactobacillus casei strain Shirota provides a positive effect on NK-cell activity.

Entities:  

Mesh:

Year:  2007        PMID: 17311976     DOI: 10.1093/jn/137.3.791S

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  33 in total

1.  Selective effects of Lactobacillus casei Shirota on T cell activation, natural killer cell activity and cytokine production.

Authors:  H Dong; I Rowland; K M Tuohy; L V Thomas; P Yaqoob
Journal:  Clin Exp Immunol       Date:  2010-05-07       Impact factor: 4.330

2.  Oral supplementation with Lactobacillus delbrueckii subsp. bulgaricus 8481 enhances systemic immunity in elderly subjects.

Authors:  Marco Antonio Moro-García; Rebeca Alonso-Arias; Maria Baltadjieva; Carlos Fernández Benítez; Manuel Amadeo Fernández Barrial; Enrique Díaz Ruisánchez; Ricardo Alonso Santos; Magdalena Alvarez Sánchez; Juan Saavedra Miján; Carlos López-Larrea
Journal:  Age (Dordr)       Date:  2012-05-30

3.  Gut-targeted immunonutrition boosting natural killer cell activity using Saccharomyces boulardii lysates in immuno-compromised healthy elderly subjects.

Authors:  Yasuhiro Naito; Francesco Marotta; Makoto K Kantah; Nicola Zerbinati; Almagul Kushugulova; Zhaxybay Zhumadilov; Nicola Illuzzi; Chiara Sapienza; Hiroshi Takadanohara; Riyichi Kobayashi; Roberto Catanzaro
Journal:  Rejuvenation Res       Date:  2014-04-11       Impact factor: 4.663

Review 4.  Compositional dynamics of the human intestinal microbiota with aging: implications for health.

Authors:  B Lakshminarayanan; C Stanton; P W O'Toole; R P Ross
Journal:  J Nutr Health Aging       Date:  2014-11       Impact factor: 4.075

5.  Immunomodulatory effects of a probiotic drink containing Lactobacillus casei Shirota in healthy older volunteers.

Authors:  Honglin Dong; Ian Rowland; Linda V Thomas; Parveen Yaqoob
Journal:  Eur J Nutr       Date:  2013-01-10       Impact factor: 5.614

Review 6.  Therapeutical use of probiotic formulations in clinical practice.

Authors:  T Iannitti; B Palmieri
Journal:  Clin Nutr       Date:  2010-06-23       Impact factor: 7.324

7.  Sulforaphane enhances apoptosis induced by Lactobacillus pentosus strain S-PT84 via the TNFα pathway in human colon cancer cells.

Authors:  Shusuke Yasuda; Mano Horinaka; Toshiyuki Sakai
Journal:  Oncol Lett       Date:  2019-08-14       Impact factor: 2.967

8.  Coexpression of bile salt hydrolase gene and catalase gene remarkably improves oxidative stress and bile salt resistance in Lactobacillus casei.

Authors:  Guohong Wang; Sheng Yin; Haoran An; Shangwu Chen; Yanling Hao
Journal:  J Ind Microbiol Biotechnol       Date:  2010-09-21       Impact factor: 3.346

9.  Fermented Milk Containing Lactobacillus casei Strain Shirota Preserves the Diversity of the Gut Microbiota and Relieves Abdominal Dysfunction in Healthy Medical Students Exposed to Academic Stress.

Authors:  Akito Kato-Kataoka; Kensei Nishida; Mai Takada; Mitsuhisa Kawai; Hiroko Kikuchi-Hayakawa; Kazunori Suda; Hiroshi Ishikawa; Yusuke Gondo; Kensuke Shimizu; Takahiro Matsuki; Akira Kushiro; Ryoutaro Hoshi; Osamu Watanabe; Tomoki Igarashi; Kouji Miyazaki; Yuki Kuwano; Kazuhito Rokutan
Journal:  Appl Environ Microbiol       Date:  2016-05-31       Impact factor: 4.792

10.  Effects of the enteral administration of Bifidobacterium breve on patients undergoing chemotherapy for pediatric malignancies.

Authors:  Mariko Wada; Satoru Nagata; Masahiro Saito; Toshiaki Shimizu; Yuichiro Yamashiro; Takahiro Matsuki; Takashi Asahara; Koji Nomoto
Journal:  Support Care Cancer       Date:  2009-08-14       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.